National Bank Financial Lowers Roots (TSE:ROOT) to Sector Perform

Share on StockTwits

National Bank Financial lowered shares of Roots (TSE:ROOT) from an outperform rating to a sector perform rating in a report issued on Tuesday, BayStreet.CA reports. They currently have C$4.25 target price on the stock, down from their prior target price of C$5.00.

Several other analysts have also recently commented on ROOT. Royal Bank of Canada dropped their price target on Roots from C$5.00 to C$4.50 and set a sector perform rating for the company in a research report on Friday, June 7th. BMO Capital Markets dropped their price target on Roots from C$6.00 to C$5.50 in a research report on Friday, June 14th. TD Securities dropped their price target on Roots from C$6.50 to C$6.00 and set a buy rating for the company in a research report on Thursday, June 13th. Finally, CIBC dropped their price target on Roots from C$5.00 to C$4.50 in a research report on Friday, June 14th.

Shares of ROOT opened at C$3.08 on Tuesday. The company has a debt-to-equity ratio of 127.51, a quick ratio of 0.09 and a current ratio of 0.88. Roots has a one year low of C$2.91 and a one year high of C$10.45. The stock has a market capitalization of $141.52 million and a price-to-earnings ratio of 18.12. The stock has a 50 day moving average price of C$3.46 and a 200 day moving average price of C$3.92.

Roots Company Profile

Roots Corporation, together with its subsidiaries, provides women's, men's, kids, toddler, and baby apparel; leather goods; footwear; and accessories under the Roots brand. The company operates through two segments, Direct-To-Consumer, and Partners and Other. The Direct-to-Consumer segment sells products through the company's corporate retail stores and e-commerce.

Read More: How does new data get added to a blockchain?

Receive News & Ratings for Roots Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roots and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Clinigen Group  Upgraded at Zacks Investment Research
Clinigen Group Upgraded at Zacks Investment Research
CHINA COAL ENER/ADR  Upgraded by Zacks Investment Research to Buy
CHINA COAL ENER/ADR Upgraded by Zacks Investment Research to Buy
CHINA COMMUNICA/ADR  Upgraded to “Hold” by Zacks Investment Research
CHINA COMMUNICA/ADR Upgraded to “Hold” by Zacks Investment Research
Bank of East Asia  Upgraded to Hold at Zacks Investment Research
Bank of East Asia Upgraded to Hold at Zacks Investment Research
Bay Banks of Virginia  Upgraded by Zacks Investment Research to Buy
Bay Banks of Virginia Upgraded by Zacks Investment Research to Buy
Aerpio Pharmaceuticals  Lowered to Hold at Zacks Investment Research
Aerpio Pharmaceuticals Lowered to Hold at Zacks Investment Research


© 2006-2019 Ticker Report